US Stock MarketDetailed Quotes

ONCY Oncolytics Biotech

Watchlist
  • 1.070
  • -0.010-0.93%
Close May 31 16:00 ET
  • 1.100
  • +0.030+2.80%
Post 16:47 ET
81.16MMarket Cap-3664P/E (TTM)

Oncolytics Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
29.58%8.73M
25.51%33.79M
4.01%8.85M
82.31%11.05M
18.43%7.16M
6.72%6.73M
2.63%26.92M
14.13%8.51M
-1.54%6.06M
-10.09%6.05M
Selling and administrative expenses
-6.64%2.98M
41.25%15.68M
14.49%4.08M
124.68%5.13M
22.56%3.36M
22.79%3.2M
-13.71%11.1M
7.32%3.57M
-20.56%2.29M
--2.74M
-General and administrative expense
-6.64%2.98M
41.25%15.68M
14.49%4.08M
124.68%5.13M
22.56%3.36M
22.79%3.2M
-13.71%11.1M
7.32%3.57M
-20.56%2.29M
--2.74M
Research and development costs
62.28%5.74M
14.76%17.71M
-3.80%4.66M
57.99%5.81M
15.51%3.7M
-4.56%3.54M
19.44%15.43M
31.61%4.84M
12.18%3.68M
0.03%3.2M
Depreciation amortization depletion
----
2.81%403K
8.08%107K
6.19%103K
-2.04%96K
----
-13.27%392K
--99K
--97K
--98K
-Depreciation and amortization
----
2.81%403K
8.08%107K
6.19%103K
-2.04%96K
----
-13.27%392K
--99K
--97K
--98K
Operating profit
-29.58%-8.73M
-25.51%-33.79M
-4.01%-8.85M
-82.31%-11.05M
-18.43%-7.16M
-6.72%-6.73M
-2.63%-26.92M
-14.13%-8.51M
1.54%-6.06M
10.09%-6.05M
Net non-operating interest income expense
68.30%446K
151.14%1.33M
55.73%489K
108.90%305K
444.90%267K
1,372.22%265K
433.33%528K
1,292.89%314K
467.21%146K
67.67%49K
Non-operating interest income
68.30%446K
151.14%1.33M
55.73%489K
108.90%305K
444.90%267K
1,372.22%265K
433.33%528K
1,292.89%314K
467.21%146K
67.67%49K
Other net income (expense)
4,231.25%1.39M
192.40%4.81M
1,569.97%4.45M
-45.29%825K
-154.05%-501K
106.57%32K
1,482.35%1.65M
-9.48%-303K
19.28%1.51M
268.18%927K
Gain on sale of security
4,231.25%1.39M
192.40%4.81M
1,569.97%4.45M
-45.29%825K
-154.05%-501K
106.57%32K
1,482.35%1.65M
-9.48%-303K
19.28%1.51M
268.18%927K
Income before tax
-7.10%-6.89M
-11.73%-27.66M
54.03%-3.91M
-125.10%-9.92M
-45.84%-7.39M
5.04%-6.44M
5.73%-24.75M
-10.22%-8.5M
9.43%-4.41M
30.03%-5.07M
Income tax
15.48%97K
-24.56%43K
250.00%7K
88.00%47K
71.43%84K
36.20%57K
-72.03%2K
25K
Net income
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
5.58%-24.84M
-10.36%-8.55M
9.53%-4.41M
29.69%-5.1M
Net income continuous Operations
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
5.58%-24.84M
-10.36%-8.55M
9.53%-4.41M
29.69%-5.1M
Minority interest income
Net income attributable to the parent company
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
5.58%-24.84M
-10.36%-8.55M
9.53%-4.41M
29.69%-5.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
5.58%-24.84M
-10.36%-8.55M
9.53%-4.41M
29.69%-5.1M
Basic earnings per share
10.00%-0.09
4.65%-0.41
66.67%-0.05
-75.00%-0.14
-33.33%-0.12
16.67%-0.1
12.24%-0.43
-7.14%-0.15
11.11%-0.08
30.77%-0.09
Diluted earnings per share
10.00%-0.09
4.65%-0.41
66.67%-0.05
-75.00%-0.14
-33.33%-0.12
16.67%-0.1
12.24%-0.43
-7.14%-0.15
11.11%-0.08
30.77%-0.09
Dividend per share
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 29.58%8.73M25.51%33.79M4.01%8.85M82.31%11.05M18.43%7.16M6.72%6.73M2.63%26.92M14.13%8.51M-1.54%6.06M-10.09%6.05M
Selling and administrative expenses -6.64%2.98M41.25%15.68M14.49%4.08M124.68%5.13M22.56%3.36M22.79%3.2M-13.71%11.1M7.32%3.57M-20.56%2.29M--2.74M
-General and administrative expense -6.64%2.98M41.25%15.68M14.49%4.08M124.68%5.13M22.56%3.36M22.79%3.2M-13.71%11.1M7.32%3.57M-20.56%2.29M--2.74M
Research and development costs 62.28%5.74M14.76%17.71M-3.80%4.66M57.99%5.81M15.51%3.7M-4.56%3.54M19.44%15.43M31.61%4.84M12.18%3.68M0.03%3.2M
Depreciation amortization depletion ----2.81%403K8.08%107K6.19%103K-2.04%96K-----13.27%392K--99K--97K--98K
-Depreciation and amortization ----2.81%403K8.08%107K6.19%103K-2.04%96K-----13.27%392K--99K--97K--98K
Operating profit -29.58%-8.73M-25.51%-33.79M-4.01%-8.85M-82.31%-11.05M-18.43%-7.16M-6.72%-6.73M-2.63%-26.92M-14.13%-8.51M1.54%-6.06M10.09%-6.05M
Net non-operating interest income expense 68.30%446K151.14%1.33M55.73%489K108.90%305K444.90%267K1,372.22%265K433.33%528K1,292.89%314K467.21%146K67.67%49K
Non-operating interest income 68.30%446K151.14%1.33M55.73%489K108.90%305K444.90%267K1,372.22%265K433.33%528K1,292.89%314K467.21%146K67.67%49K
Other net income (expense) 4,231.25%1.39M192.40%4.81M1,569.97%4.45M-45.29%825K-154.05%-501K106.57%32K1,482.35%1.65M-9.48%-303K19.28%1.51M268.18%927K
Gain on sale of security 4,231.25%1.39M192.40%4.81M1,569.97%4.45M-45.29%825K-154.05%-501K106.57%32K1,482.35%1.65M-9.48%-303K19.28%1.51M268.18%927K
Income before tax -7.10%-6.89M-11.73%-27.66M54.03%-3.91M-125.10%-9.92M-45.84%-7.39M5.04%-6.44M5.73%-24.75M-10.22%-8.5M9.43%-4.41M30.03%-5.07M
Income tax 15.48%97K-24.56%43K250.00%7K88.00%47K71.43%84K36.20%57K-72.03%2K25K
Net income -7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M5.58%-24.84M-10.36%-8.55M9.53%-4.41M29.69%-5.1M
Net income continuous Operations -7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M5.58%-24.84M-10.36%-8.55M9.53%-4.41M29.69%-5.1M
Minority interest income
Net income attributable to the parent company -7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M5.58%-24.84M-10.36%-8.55M9.53%-4.41M29.69%-5.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M5.58%-24.84M-10.36%-8.55M9.53%-4.41M29.69%-5.1M
Basic earnings per share 10.00%-0.094.65%-0.4166.67%-0.05-75.00%-0.14-33.33%-0.1216.67%-0.112.24%-0.43-7.14%-0.1511.11%-0.0830.77%-0.09
Diluted earnings per share 10.00%-0.094.65%-0.4166.67%-0.05-75.00%-0.14-33.33%-0.1216.67%-0.112.24%-0.43-7.14%-0.1511.11%-0.0830.77%-0.09
Dividend per share
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg